ReviewFrontiers in immunology2026
Compartmental immunity in intra-abdominal infection: from peritoneal defense to systemic sepsis.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Targeting the remodeled peritoneal ecosystem: a paradigm shift from tumor cells to the microenvironment in gastric cancer peritoneal metastasis.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Complicated intra-abdominal infection (cIAI) represents a common and challenging surgical emergency that frequently progresses from localized infection to intra-abdominal sepsis (IAS), leading to rapid clinical deterioration, early organ dysfunction, and unfavorable outcomes. However, the immunological mechanisms underlying these clinical behaviors remain incompletely understood. This review advances a compartment-oriented immunopathological framework to explain the unique behavior of abdominal infection across the cIAI-IAS spectrum. The peritoneal cavity is not an immunologically passive space but a highly specialized immune compartment pre-equipped with fat-associated lymphoid clusters (milky spots), peritoneal resident macrophages (PRMs), B1 cells, and innate lymphoid cells (ILCs). Upon intra-abdominal contamination, this regional immune network enables rapid and high-intensity local inflammatory responses that initially favor containment of polymicrobial infection. However, inadequate or delayed multimodal intervention, together with unfavorable host conditions such as advanced age, immunosuppression, comorbidities, and high disease severity, may permit excessive inflammatory amplification and peritoneal barrier failure within this confined anatomical space. As a consequence, pathogen- and injury-associated signals disseminate rapidly through vascular and lymphatic pathways, driving progression from cIAI to IAS. Together, this compartment-oriented perspective challenges the traditionally source control-focused understanding of cIAI by highlighting the critical role of peritoneal immune compartmentalization, opening avenues for earlier risk stratification and immunologically informed, stratified intervention strategies across the full cIAI-IAS spectrum.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.